The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis ; volume:20 ; number:1 ; day:21 ; month:9 ; year:2020 ; pages:1-9 ; date:12.2020
BMC cancer ; 20, Heft 1 (21.9.2020), 1-9, 12.2020

Creator: Vuong, Huy Gia
Nguyen, Thu Quynh
Ngo, Tam N. M.
Nguyen, Hoang Cong
Fung, Kar-Ming
Dunn, Ian F.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12885-020-07364-5

URN: urn:nbn:de:101:1-2020110820190997009641

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Vuong, Huy Gia
Nguyen, Thu Quynh
Ngo, Tam N. M.
Nguyen, Hoang Cong
Fung, Kar-Ming
Dunn, Ian F.
SpringerLink (Online service)

Other Objects (12)

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Human TERT promoter mutations as a prognostic biomarker in glioma

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma

O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Frequency of TERT Promoter Mutations in Prostate Cancer

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Human TERT promoter mutations as a prognostic biomarker in glioma

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma

O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Frequency of TERT Promoter Mutations in Prostate Cancer

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Human TERT promoter mutations as a prognostic biomarker in glioma

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma

O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Frequency of TERT Promoter Mutations in Prostate Cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Human TERT promoter mutations as a prognostic biomarker in glioma

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma

O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Frequency of TERT Promoter Mutations in Prostate Cancer

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Human TERT promoter mutations as a prognostic biomarker in glioma

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma

O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Frequency of TERT Promoter Mutations in Prostate Cancer

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Human TERT promoter mutations as a prognostic biomarker in glioma

Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma

O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation

18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma

TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

TERT promoter hotspot mutations in breast cancer

Mechanistic basis of atypical TERT promoter mutations

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Frequency of TERT Promoter Mutations in Prostate Cancer

Related objects

Reset password